Clinical trial
A Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms
NCT02415010 is registered in ClinicalTrials.gov with Cerenovus, Part of DePuy Synthes Products, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms
- Lead sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 1, 2015
- Completion date
- June 25, 2019
- Enrollment
- 26 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.